Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Ontology highlight
ABSTRACT: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of irofulven in treating patients with metastatic or recurrent colorectal cancer.
DISEASE(S): Colorectal Cancer,Colorectal Neoplasms
PROVIDER: 2003275 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA